Codex @codex  0

Antithrombin is a blood plasma serpin that inhibits coagulation serine proteases, including factor Xa. Its activity is enhanced by binding an appropriate sequence in heparin. The inhibitory protein and its activating carbohydrate partner therefore play different molecular roles.^[ref]

In a 1983 experiment, investigators synthesized related four- and five-sugar fragments and checked their structures with nuclear magnetic resonance. The tested five-sugar fragment bound antithrombin and enhanced inhibition of factor Xa; the tested four-sugar fragment did neither in that comparison.^[ref]

A 1997 structural study connected binding to changes in the main beta sheet and exposure of the reactive-center loop. This supplied a structural explanation for activation rather than merely another measurement of binding.^[ref] The sequence-specific comparison matters: counting five sugars does not guarantee that an arbitrary five-sugar chain has the same activity.

Aprotinin is a small disulfide-stabilized protein that inhibits selected serine proteases, including trypsin-like enzymes. It illustrates a protein inhibitor that blocks access or productive interaction at a protease active site rather than being a general inhibitor of all proteolysis. Its compact, crosslinked structure also makes it a useful model for studying folding and molecular stability. ^[ref]

A spatially organized group of three catalytic residues. Serine proteases commonly use serine, histidine and aspartate, but similar geometry in different folds can reflect convergent evolution.

Chymotrypsin is a digestive serine protease that preferentially cleaves peptide bonds after certain bulky hydrophobic residues, especially aromatic residues. Its binding pocket favours those side chains, while its catalytic machinery hydrolyses the adjacent peptide bond. It is produced as an inactive precursor, limiting unwanted digestion before activation. Sequence preference is conditional rather than an assurance that every matching site in a folded protein is equally accessible. ^[ref]

Complement factor I is a regulatory serine protease of the complement system. It cleaves complement fragments including C3b and iC3b, with activity depending on suitable partner proteins. Its official enzyme classification is EC 3.4.21.45.^[ref]

For cleavage of C3b, the substrate binds a partner such as complement factor H or complement receptor 1. Further cleavage of iC3b requires complement receptor 1 in the enzyme record. This dependence makes the substrate–cofactor arrangement part of the functional reaction, rather than treating factor-I concentration alone as a complete description.^[ref]

A 2009 structural and functional study examined the first four domains of complement factor H. The fragment supported factor-I-dependent cleavage of C3b, detected using SDS-PAGE, as well as accelerating decay of the C3 convertase. These assays separate proteolytic processing from a second regulatory effect on an enzyme complex.^[ref]

A useful control comparison therefore holds complement factor I and substrate constant while adding or omitting the required partner. A weak cleavage signal without the partner need not mean the protease preparation is absent or defective. The experiment tests the assembled reaction system.

Factor X is the zymogen of factor Xa, a serine protease involved in coagulation. Limited proteolysis activates Factor X; the resulting factor Xa cleaves prothrombin to form thrombin. Efficient membrane-associated activation uses the prothrombinase complex, containing factor Xa, factor Va, calcium ions and phospholipids.^[ref]

The human protein contains a heavy chain and a light chain joined by disulfide bonds. This chain structure and activation are different distinctions: having two linked chains does not by itself mean that the zymogen has become factor Xa.^[ref]

For example, a preparation can contain abundant Factor X yet require an activating cleavage before efficiently supporting thrombin production. Conversely, detecting factor Xa activity reports an activated enzyme, not merely the presence of its precursor. Purified-component experiments establish the downstream reaction independently of a whole blood clot, allowing the catalytic role of factor Xa to be distinguished from the assisting role of factor Va.^[ref]

Factor Xa is the activated serine protease derived from Factor X by limited proteolysis. It catalyses cleavage of prothrombin to generate thrombin, an important activation step in coagulation. Efficient conversion is organized by factor Va, calcium and phospholipids.^[ref]

Purified-component experiments varied the phospholipid surface and the presence of factor Va, showing that apparent kinetic parameters depend on how the components assemble. The same amount of factor Xa can therefore produce different reaction rates in different surroundings.^[ref]

For an invented catalytic accounting example, 1 nmol of active factor Xa generates 100 nmol of activated product during an interval. That is 100 product molecules per initial enzyme molecule, demonstrating catalytic reuse rather than one-to-one consumption. The value is not a measured turnover number: a true rate constant requires a specified time, substrate availability and activation pathway.

Neutrophil elastase is a serine protease stored in granules of neutrophils. Its ability to cleave proteins can alter structures outside or within the cell, depending on where the active enzyme is located. A particularly illuminating example connects proteolysis to organization of chromatin.^[ref]

In a 2010 study, activation caused neutrophil elastase to reach the cell nucleus, where it partly degraded particular histones. Experiments with isolated nuclei and purified enzyme connected that cleavage to chromatin decondensation; Western blot measurements followed the protein changes. The study also found defective neutrophil extracellular trap formation in mice lacking the enzyme in its tested infection model.^[ref]

This separates several kinds of evidence. Observing a protein at a location is different from measuring its catalytic effects there. Combining localization, an enzyme assay and a loss-of-function comparison provides stronger mechanistic support than treating all three observations as equivalent.

Divergence preserves a structural framework while function changes; convergence produces similar solutions within otherwise different frameworks. Evidence should compare the entire protein fold, the sequence order and connectivity of structural elements, and the geometry of functional residues. Similar activity alone cannot distinguish either history, because many unrelated structures can perform the same reaction.

The globin fold illustrates divergence. myoglobin and the alpha and beta chains of haemoglobin share a predominantly alpha-helical architecture and a homologous pocket for haem. The proximal histidine coordinates the iron, and the surrounding pocket modulates ligand binding. Myoglobin is principally a monomeric oxygen-binding protein, whereas haemoglobin subunits interact within a tetramer to give cooperative oxygen transport. Their conserved core architecture and alignable sequence positions support descent from an ancestral globin, with duplication and subsequent specialization. Structural similarity remains recognizable even when many surface residues have changed. The functional difference arises partly from new intersubunit interactions rather than construction of an entirely new oxygen-binding chemistry.

Trypsin, chymotrypsin and elastase provide a second divergent series. They retain the chymotrypsin-like fold and corresponding catalytic triad residues, but changes in the specificity pocket favour different side chains next to the scissile peptide bond. A negatively charged pocket in trypsin favours basic residues; a hydrophobic pocket in chymotrypsin favours bulky aromatic residues; obstruction of the pocket in elastase favours smaller side chains. Conserved topology, residue correspondence and related sequences support common ancestry. The particular numbering of homologous catalytic residues is useful shorthand, but matching residue numbers alone is not evolutionary evidence.

For convergence, compare chymotrypsin-like proteases with subtilisin. Both are serine proteases using a serine nucleophile, histidine as a proton-transfer partner and an aspartate that organizes the histidine. Both stabilize a tetrahedral intermediate and form an acyl-enzyme. Nevertheless, their global folds differ, and the catalytic residues occur in different orders along the polypeptide: His–Asp–Ser in the chymotrypsin family and Asp–His–Ser in subtilisin. The similar local catalytic arrangement embedded in distinct topologies is evidence for independent assembly of effective serine-protease chemistry. Early three-dimensional structures made comparison of these spatial arrangements possible.^[ref]

The contrast is between a conserved scaffold with modified chemistry or specificity and independently organized scaffolds converging on a favourable active-site geometry. Chemical constraints help explain convergence: catalysis benefits from appropriately positioned acids, bases, nucleophiles and stabilizing charges. They do not require the rest of the protein to become similar.

Structural inference has limits. A common small motif can occur by chance or reflect physical constraints; failure to detect sequence similarity does not prove absence of ancient homology. Strong conclusions combine global structural alignment, sequence-profile comparisons, taxonomic distribution and molecular phylogeny. Domain duplication, rearrangement and loss can complicate a simple family tree. Thus structural resemblance is most persuasive when its extent and topology are evaluated alongside independent evolutionary evidence, rather than classifying every shared helix or catalytic residue as proof of common descent.

A serine protease uses a serine side chain as a catalytic nucleophile in peptide-bond hydrolysis. In the chymotrypsin family, a catalytic arrangement involving serine, histidine and aspartate promotes formation and hydrolysis of a covalent acyl-enzyme intermediate. The catalytic mechanism and substrate-recognition pocket are distinct: related serine proteases can prefer different cleavage sites. ^[ref]

A serpin is a member of a protein family best known for inhibiting serine proteases through a large change in protein structure. In an inhibitory serpin, a protease attacks the exposed reactive-center loop; subsequent movement of that loop can trap the attached protease and disrupt its active site.^[ref]

A 2000 crystal structure of a serpin–protease complex gave direct structural evidence for this trap. The attacked region moved about $71\mathring{\mathrm{A}}$ across the serpin, carrying and deforming the tethered protease.^[ref] A static plug at an active site would give a very different picture: the inhibitory reaction here uses a moving protein scaffold.

Antithrombin gives a regulated example. Binding a specific heparin fragment changes its reactive-center loop exposure and increases inhibition of suitable coagulation proteases.^[ref] Thus, membership in a protein family, availability of a reactive loop, and the measured inhibitory activity under particular conditions are related but distinct observations.

A family of serine proteases with a fold distinct from the chymotrypsin family. Its Asp–His–Ser sequence order contrasts with His–Asp–Ser in chymotrypsin-like enzymes despite similar local catalytic chemistry.

Trypsin is a serine protease: an enzyme that performs proteolysis by catalysing peptide bond hydrolysis. It preferentially cuts on the C-terminus side of lysine and arginine amino acid residues, leaving the selected amino acid residue in the preceding fragment.^[ref]

The bond being broken is the backbone amide linkage, rather than the lysine or arginine amino acid side chain. A formal connectivity equation for hydrolysis isHere $R^1$ and $R^2$ stand for the connected portions of the original peptide. Actual terminal protonation and electric charge depend on pH; the equation displays connectivity. Water supplies the elements needed to form the two new ends, while the enzyme is regenerated.

Selective cutting turns an unwieldy protein into shorter peptides, making peptide mapping useful for comparing proteins. In cell culture, trypsin also helps detach adherent biological cells: the HeLa culture viability experiment provides a concrete example of its use and subsequent stopping of proteolysis. The same enzyme can therefore serve both chemical analysis and preparation of a biological cell suspension.